Revenue Update on HCP(NYSE:HCP)

HCP(NYSE:HCP) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 9, 2016. Company reported revenue of $662.18M. Analysts estimated a revenue of $635.14M. Earnings per share were $0.74. Analysts had estimated an EPS of $0.70.

In a different note, Raymond James said it Initiates Coverage on HCP, according to a research note issued on Jul 26, 2016. The shares have been rated ‘Underperform’ by the firm. On Jul 8, 2016, Goldman Sachs said it Upgrades its rating on HCP. The shares have been rated ‘Neutral’ by the firm. On Jun 22, 2016, Morgan Stanley said it Downgrades its rating on HCP. The shares have been rated ‘Underweight’ by the firm. On May 16, 2016, Citigroup said it Maintains its rating on HCP. In the research note, the firm Raises the price-target to $31.00 per share. The shares have been rated ‘Neutral’ by the firm.

HCP (HCP) made into the market gainers list on Wednesdays trading session with the shares advancing 0.97% or 0.38 points. Due to strong positive momentum, the stock ended at $39.61, which is also near the day’s high of $39.745. The stock began the session at $39.31 and the volume stood at 56,60,115 shares. The 52-week high of the shares is $40.9 and the 52 week low is $25.1104. The company has a current market capitalization of $18,521 M and it has 46,75,83,450 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On May 11, 2016, Kai Hsiao (Executive Vice President) sold 266 shares at $36.04 per share price.Also, On Feb 17, 2016, John D. Stasinos (Executive Vice President) purchased 400 shares at $26.24 per share price.On Feb 16, 2016, Troy E. Mchenry (EVP, Gen Counsel and Corp Sec) purchased 1,000 shares at $25.75 per share price, according to the Form-4 filing with the securities and exchange commission.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *